Andreas Wagner Sells 21,118 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 21,118 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total transaction of $393,217.16. Following the sale, the insider owned 148,687 shares of the company’s stock, valued at $2,768,551.94. This trade represents a 12.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Alignment Healthcare Price Performance

Shares of ALHC stock traded up $0.43 during midday trading on Wednesday, reaching $18.88. 3,557,099 shares of the company traded hands, compared to its average volume of 2,956,721. The firm has a market cap of $3.86 billion, a PE ratio of -1,886.11, a price-to-earnings-growth ratio of 3.12 and a beta of 1.18. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The firm’s 50 day simple moving average is $20.96 and its two-hundred day simple moving average is $18.63.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. The firm had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.53%. The firm’s revenue for the quarter was up 44.4% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.16) EPS. On average, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. UBS Group increased their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, January 14th. KeyCorp restated an “overweight” rating and issued a $28.00 price objective on shares of Alignment Healthcare in a research note on Thursday, January 22nd. TD Cowen boosted their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research report on Friday, January 16th. Finally, Piper Sandler boosted their price objective on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $24.56.

Institutional Investors Weigh In On Alignment Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Allworth Financial LP grew its stake in Alignment Healthcare by 8.9% during the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock worth $137,000 after buying an additional 566 shares in the last quarter. State of Alaska Department of Revenue grew its stake in Alignment Healthcare by 6.0% during the fourth quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company’s stock worth $223,000 after purchasing an additional 636 shares during the period. Integrated Wealth Concepts LLC increased its stake in Alignment Healthcare by 6.3% in the third quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock valued at $196,000 after purchasing an additional 665 shares in the last quarter. Parallel Advisors LLC lifted its holdings in shares of Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in Alignment Healthcare by 2.3% during the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company’s stock valued at $659,000 after purchasing an additional 844 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.